APA (7th ed.) Citation

JJ, K., KT, S., J, K., MA, S., EA, B., S, S., . . . K, C. (2021). Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS medicine, 18(3), e1003534. https://doi.org/10.1371/journal.pmed.1003534

Chicago Style (17th ed.) Citation

JJ, Kim, Simms KT, Killen J, Smith MA, Burger EA, Sy S, Regan C, and Canfell K. "Human Papillomavirus Vaccination for Adults Aged 30 to 45 Years in the United States: A Cost-effectiveness Analysis." PLoS Medicine 18, no. 3 (2021): e1003534. https://doi.org/10.1371/journal.pmed.1003534.

MLA (9th ed.) Citation

JJ, Kim, et al. "Human Papillomavirus Vaccination for Adults Aged 30 to 45 Years in the United States: A Cost-effectiveness Analysis." PLoS Medicine, vol. 18, no. 3, 2021, p. e1003534, https://doi.org/10.1371/journal.pmed.1003534.